Kura Oncology
KURA
$20.59
Share price
1.53%
Change (1 day)
97.22%
Change (1 year)
Categories
Kura Oncology (KURA) - P/B ratio
P/B ratio as of May 2024 : 3.89
According to Kura Oncology
's latest financial reports the company has a price-to-book ratio of 3.89.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Kura Oncology - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.69 | 36.1% |
| 2022-12-31 | 1.98 | 7.4% |
| 2021-12-31 | 1.84 | -47.9% |
| 2020-12-31 | 3.53 | 23.77% |
| 2019-12-31 | 2.85 | -14.27% |
| 2018-12-31 | 3.33 | -42.52% |
| 2017-12-31 | 5.79 | 161.15% |
| 2016-12-31 | 2.22 | 1.38% |
| 2015-12-31 | 2.19 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.81 | -27.82% | 🇺🇸 USA |